Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

IQVIA Holdings, Inc. Common Stock (NY: IQV )

193.44 -2.61 (-1.33%)
Official Closing Price Updated: 7:00 PM EST, Feb 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about IQVIA Holdings, Inc. Common Stock

< Previous 1 2 3 4 5 Next >
IQVIA Reports Fourth-Quarter and Full-Year 2024 Results; Reaffirms Full-Year 2025 Guidance
From IQVIA Holdings Inc.
Via Business Wire
IQVIA named to the Fortune® World’s Most Admired Companies™ list, ranked No. 1 in its sector for fourth consecutive year
From IQVIA
Via Business Wire
IQVIA to Announce Fourth-Quarter and Full-Year 2024 Results on February 6, 2025
From IQVIA
Via Business Wire
IQVIA and NVIDIA Collaborate to Transform Healthcare and Life Sciences Through Advanced Agentic AI Solutions
From IQVIA
Via Business Wire
Digital Health Tools are Expanding in Scope and Function to Aid Patient Diagnosis, Treatment and Monitoring, Says New Report from The IQVIA Institute
From IQVIA
Via Business Wire
IQVIA CFO Ron Bruehlman to Speak at the UBS Global Healthcare Conference on November 13, 2024
From IQVIA Holdings Inc.
Via Business Wire
IQVIA Reports Third-Quarter 2024 Results and Announces Investor Day
From IQVIA Holdings Inc.
Via Business Wire
IQVIA to Announce Third-Quarter 2024 Results on October 31, 2024
From IQVIA Holdings Inc.
Via Business Wire
IQVIA Announces IQVIA AI Assistant, Powered by IQVIA Healthcare-grade AI™
From IQVIA
Via Business Wire
IQVIA AI Solution Receives 2024 Frost & Sullivan Global Customer Value Leadership Award
From IQVIA
Via Business Wire
IQVIA CFO Ron Bruehlman to Speak at the Morgan Stanley Annual Global Healthcare Conference on September 4, 2024
From IQVIA Holdings Inc.
Via Business Wire
How A.I. Is Shaping the Future of U.S. Healthcare: Regulatory and Market Updates
EQNX::TICKER_START (OTCQB:AVAI),(NASDAQ:RXRX),(NASDAQ:EXAI),(NASDAQ:TWST),(NYSE:IQV) EQNX::TICKER_END 
Via FinancialNewsMedia
Topics Artificial Intelligence
Exposures Artificial Intelligence
IQVIA Reports Second-Quarter 2024 Results
From IQVIA Holdings Inc.
Via Business Wire
How A.I. Is Shaping the Future of U.S. Healthcare: Regulatory and Market Updates
From FN Media Group LLC
Via GlobeNewswire
IQVIA Named a Leader in Medical Affairs and Regulatory Operations by Everest Group
From IQVIA
Via Business Wire
IQVIA to Announce Second-Quarter 2024 Results on July 22, 2024
From IQVIA Holdings Inc.
Via Business Wire
IQVIA’s SmartSolve® eQMS Wins 2024 MedTech Breakthrough Award “Best Use of Artificial Intelligence in Healthcare”
From IQVIA
Via Business Wire
IQVIA Launches “One Home” Clinical Trial Technology Platform – Solves Challenges and Reduces Overload at Sites
From IQVIA
Via Business Wire
IQVIA Institute: Innovative Therapies and Strong Pipeline to Combat Rise in Cancer Diagnoses
From IQVIA
Via Business Wire
U.S. Medicines Spending Grew in 2023 as Greater Access Offset COVID-19-related Decline, Says IQVIA Institute
From IQVIA
Via Business Wire
IQVIA CFO Ron Bruehlman to Speak at the Bank of America Health Care Conference on May 14, 2024
From IQVIA Holdings Inc.
Via Business Wire
IQVIA Reports First-Quarter 2024 Results
From IQVIA Holdings Inc.
Via Business Wire
IQVIA Celebrates Wendy Stewart and Susan Barnes, Winners of Healthcare Businesswoman's Association Luminary and Rising Star Awards
From IQVIA
Via Business Wire
IQVIA to Announce First-Quarter 2024 Results on May 2, 2024
From IQVIA Holdings Inc.
Via Business Wire
IQVIA and Salesforce Expand Global Partnership to Accelerate the Development of Life Sciences Cloud
From IQVIA
Via Business Wire
IQVIA CFO Ron Bruehlman to Speak at Barclays Annual Global Healthcare Conference on March 13, 2024
From IQVIA Holdings Inc.
Via Business Wire
IQVIA Publishes its 2023 Environmental, Social and Governance Report
From IQVIA
Via Business Wire
Global Biopharma R&D Boasts Increased Funding, Productivity and Product Launches in 2023, says IQVIA Institute Report
From IQVIA
Via Business Wire
IQVIA CFO Ron Bruehlman to Speak at Citi’s Unplugged Medtech and Life Sciences Access Day on February 29, 2024
From IQVIA Holdings Inc.
Via Business Wire
IQVIA Reports Fourth-Quarter and Full-Year 2023 Results; Issues Full-Year 2024 Guidance
From IQVIA Holdings Inc.
Via Business Wire
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.